Sign in Create account

Apollo Hospitals Enterprise Limited

Healthcare · Healthcare Services

NSE: APOLLOHOSP BSE: 508869
₹8165.50
▼ -493.50 (-5.70%)
Sept. 30, 2026 · NSE · nse_bhavcopy
Quality
73/100
Strong
Valuation
—/100
Expensive
Momentum
27/100
Bearish

QVM read Quality, pricey and fading Quality Strong, Valuation Expensive, Momentum Bearish

Tradinity's own scoring, not a copy of any third party's -- see the Key Metrics section for the real ratios behind each number.

About

Apollo Hospitals Enterprise Limited is an Indian multinational healthcare group headquartered in Chennai. It is the second largest for-profit private hospital network in India after Manipal Hospitals, with a network of 71 owned and managed hospitals. Along with the eponymous hospital chain, the company also operates pharmacies, primary care and diagnostic centres, telehealth clinics, and digital healthcare services among others through its subsidiaries.

Source: Wikipedia

Key Metrics

Market Capitalization
₹117,407 Cr
PE (TTM)
74.7
Industry median 50.2 (44 companies)
Price to Book
11.8
PEG (TTM)
4.6
Institutions holding %
65.22%
FII + DII, latest filed period
Piotroski Score
8
Relative return vs Nifty50, qtr %
-0.5
Relative return vs Sector, qtr %
-2.5
Free Cash Flow
₹894 Cr
as of March 31, 2026
Industry median ₹1 Cr (75 companies)
EPS Growth (YoY)
25.48%
as of June 30, 2026
Industry median 13.27% (57 companies)
Net Profit Growth (TTM)
16.24%
as of June 30, 2026
Industry median 7.21% (57 companies)
Operating Revenue Growth (TTM)
16.38%
as of June 30, 2026
Industry median 12.82% (57 companies)
Profit Growth (YoY)
25.51%
as of June 30, 2026
Industry median 8.53% (57 companies)
Revenue Growth (YoY)
22.52%
as of June 30, 2026
Industry median 18.84% (52 companies)
Current Ratio
1.06
as of March 31, 2026
Industry median 2.06 (74 companies)
Debt to Equity
0.57
as of March 31, 2026
Industry median 0.11 (62 companies)
Interest Coverage
9.16
as of June 30, 2026
Industry median 7.94 (57 companies)
Net Margin
14.50%
as of June 30, 2026
Industry median 9.88% (61 companies)
Operating Margin (EBIT)
21.42%
as of June 30, 2026
Industry median 17.21% (61 companies)
Operating Margin (TTM)
23.45%
as of June 30, 2026
Industry median 16.20% (59 companies)
Return on Assets
9.02%
as of March 31, 2026
Industry median 5.40% (58 companies)
Return on Capital Employed
19.51%
as of March 31, 2026
Industry median 10.44% (56 companies)
Return on Equity
20.08%
as of March 31, 2026
Industry median 10.16% (58 companies)

Investment checklist

Tradinity's own yes/no questions with the rule stated beside each. “Items without enough data are left out, never counted as a No, and the totals count only answered questions. A summary of numbers on this page, not advice.

Financials

7 of 8 met
  • Yes Net profit is higher than a year earlier in each of the last 4 quarters
  • Yes Revenue is higher than a year earlier in each of the last 4 quarters
  • Yes Quality score is Strong (70 or more)
  • Yes Piotroski F-score is 7 or more (score 8)
  • No Debt to equity is below 0.5 (0.57)
  • Yes Return on equity is 15% or more (20.1%)
  • Yes Net cash flow for the latest year is positive
  • Yes Cash from operations is higher than the year before

Ownership

4 of 4 met
  • Yes FII/FPI or DII holding rose in the latest quarter
  • Yes Promoter holding rose or was unchanged in the latest quarter
  • Yes Promoter pledge is 5% of their holding or less and not rising (2.5% pledged)
  • Yes Insiders have not sold in the past 3 months (no open-market sale filed in the last 3 months)

Peer comparison

3 of 3 met
  • Yes 1-year return beats the industry median
  • Yes Revenue growth beats the industry median
  • Yes Profit growth beats the industry median

Value and momentum

1 of 6 met
  • Yes Price sits in the Buy zone of its own historical PE range (Buy Zone)
  • No Valuation score is Undervalued (70 or more)
  • No Momentum score is Bullish (70 or more)
  • No Price is above the 5, 10 and 20 day averages
  • No Price is above the 50, 100 and 200 day averages
  • No Latest candle has a bullish shape (hammer, dragonfly doji, white marubozu)

Price

Download CSV

PE/EPS use each quarter's real filed EPS only from 45 days after quarter-end (no look-ahead) against the raw close of the day. Price-to-book isn't a mode here: the feed has no dated share count, so there's no real history to chart.

RSI (14) (same adjusted close series as the price chart above)

MACD (12, 26, 9) (same adjusted close series as the price chart above)

Relative Returns (vs NIFTY 50)

Prices adjusted for splits and bonuses. * = a corporate action affecting this date could not be parsed and is not reflected.

Price range

Day return
-5.7%
Low 8053.0000 · High 8659.0000
1W return
-10.0%
Low 8053.0000 · High 9069.0000
1M return
-8.2%
Low 8053.0000 · High 9070.5000
52W return
9.7%
Low 6696.5000 · High 9070.5000
Lifetime High ₹9069.0000 (Sept. 23, 2026)
Lifetime Low ₹22.0000 (Feb. 8, 1999)

Full price history and technicals →

Technicals

Full technicals, indicators & Volume/Delivery →

EMA & SMA

Bullish1
Bearish5
5D
8596.8
10D
8714.1
20D
8768.3
50D
8754.9
100D
8555.7
200D
8013.9

Delivery and volume

Day avg. delivery
55.5%
Week avg. delivery
62.6%
Month avg. delivery
63.2%

Week = 5 sessions, Month = 22 sessions ending the latest trading day — the same combined NSE+BSE delivery data as the table below, just summed.

Resistance and support

8292.50
Pivot
First resistance8532.00
Second resistance8898.50
Third resistance9138.00
First support7926.00
Second support7686.50
Third support7320.00
Day RSI30.7
Day MFI23.6
Day MACD-44.50
Day MACD signal5.74

Beta

1M0.82
3M0.39
1Y0.52
3Y0.60

Price change analysis

↓ -8.2%
Over 1 Month
LowHigh
8053.009070.50
↓ -5.3%
Over 3 Months
LowHigh
8053.009070.50
↑ 11.8%
Over 6 Months
LowHigh
7150.509070.50
↑ 9.7%
Over 1 Year
LowHigh
6696.509070.50
Legend Positive indicator Neutral indicator Negative indicator

Buy/Sell Zone

View Buy/Sell Zone →
Current PE 74.7 (own history: 70.1–92.2)
Buy Zone

Financials

View full financials, peers & valuation multiples →
Revenue (June 30, 2026)
₹2,656 Cr
Net profit (June 30, 2026)
₹385 Cr
Basic EPS (June 30, 2026)
₹26.7900

Ranks #1 of 62 in Healthcare Services by market cap -- full peer table on the Financials page.

Shareholding pattern / Ownership

Shareholding summary

Jun 2026
  • Promoter28.02%
  • Mutual funds17.33%
  • FII/FPI41.50%
  • Other DII6.39%
  • Public6.76%

Largest holders

NameCategoryShares %Shares
M/s. PCR Investments LtdPromoter18.9300%27223124
SBI NIFTY 50 ETFPublic2.3200%3333586
Ms. Suneeta ReddyPromoter2.0400%2937066
LIFE INSURANCE CORPORATION OF INDIAPublic1.9700%2830488
AXIS MUTUAL FUND TRUSTEE LIMITEDPublic1.7900%2578658

As of June 30, 2026. Only holders the filing discloses individually.

Historical promoter holding

Promoters holdings were unchanged at 28.02% in Jun 2026 qtr

Historical fii holding

FII/FPI holdings decreased from 42.62% to 41.50% in Jun 2026 qtr

Historical mutual fund holding

Mutual funds holdings increased from 16.65% to 17.33% in Jun 2026 qtr

120 mutual fund schemes also hold this stock.

All shareholding details →

Insider trading, SAST & pledges

All 197 insider trades, 62 SAST, 184 pledge events →

Latest insider trades

FiledPersonCategoryTypeQuantityValue
30 Dec 2025 KARTHIK ANAND Promoter Sell 0 ₹0
30 Dec 2025 HARSHAD REDDY Promoter Sell 0 ₹0
30 Dec 2025 p vijayakumar reddy Promoter Buy 0 ₹0
18 Nov 2025 SUNEETA REDDY Promoter Pledge Revoke 0 ₹112.31 Cr
17 Oct 2025 PCR INVESTMENTS LIMITED Promoter Pledge Revoke 0 ₹180.71 Cr
30 Sep 2025 K VISHWESHWAR REDDY Promoter Pledge 0 ₹52.11 Cr
12 Sep 2025 SUNEETA REDDY Promoter Pledge Revoke 0 ₹137.89 Cr
10 Sep 2025 K VISHWESHWAR REDDY Promoter Pledge Revoke 0 ₹219.62 Cr
5 Sep 2025 SUNEETA REDDY Promoter Pledge Revoke 0 ₹444.82 Cr
30 Aug 2025 PCR INVESTMENTS LIMITED Promoter Pledge Revoke 0 ₹946.68 Cr

All insider and SAST disclosures →

Deals (Bulk & Block)

All 241 deals, with filters and CSV →
DateClientDealActionQuantityPriceExchange
19 Nov 2025 KADENSA MASTER FUND Block Buy 59,584 7312.0000 NSE
19 Nov 2025 BOFA SECURITIES EUROPE SA Block Sell 59,584 7312.0000 NSE
10 Nov 2025 GOLDMAN SACHS BANK EUROPESE-ODI Block Sell 92,363 7474.0000 NSE
10 Nov 2025 BOFA SECURITIES EUROPE SA Block Buy 92,363 7474.0000 NSE
17 Sep 2025 GOLDMAN SACHS BANK EUROPE SE - ODI Block Buy 52,098 7852.5000 NSE
17 Sep 2025 GOLDMAN SACHS (SINGAPORE) PTE - ODI Block Sell 52,098 7852.5000 NSE
15 Sep 2025 GOLDMAN SACHS BANK EUROPE SE - ODI Block Buy 40,265 7874.5000 NSE
15 Sep 2025 GOLDMAN SACHS (SINGAPORE) PTE - ODI Block Sell 40,265 7874.5000 NSE
9 Sep 2025 GOLDMAN SACHS BANK EUROPE SE - ODI Block Buy 43,031 7786.5000 NSE
9 Sep 2025 GOLDMAN SACHS (SINGAPORE) PTE - ODI Block Sell 43,031 7786.5000 NSE

All bulk and block deals →

Board Meetings

View board meeting history →

Quarterly results, AGMs, buybacks and other board-approved business.

DatePurposeResults
12 Aug 2026 Financial Results/Other business matters Yes
20 May 2026 Financial Results/Dividend/Other business matters Yes
10 Feb 2026 Financial Results/Other business matters Yes
10 Feb 2026 Financial Results/Dividend/Other business matters Yes
6 Nov 2025 Financial Results/Other business matters Yes

Corporate Announcements

All 1 announcements, with search →

Exchange disclosures (NSE and BSE), most recent first.

DateCategoryAnnouncement
25 Sep 2026 Insider Trading / SAST Apollo Hospitals Enterprise Ltd - 508869 - Closure of Trading Window

All announcements →

SWOT

Tradinity's own rule-based read of the real ratios elsewhere on this page -- not a copy of any third party's, and never a forward-looking prediction.

Strengths

  • Strong revenue growth YoY (22.5%)

Weaknesses

Data unavailable.

Opportunities

Data unavailable.

Threats

  • PE above 35 (74.7) -- priced for continued strong execution

Board of directors and corporate information →

F&O

View F&O, Options & Backtest →

Single-stock futures and a real listed options chain available for this stock -- OI buildup, PCR, Max Pain and Greeks are all on the full F&O page.

Part of: NIFTY 100, NIFTY 100, NIFTY 200, NIFTY 200, NIFTY 50, NIFTY 50, NIFTY 500, NIFTY 500

Frequently asked questions about Apollo Hospitals Enterprise Limited

Where is the share price?

The price at the top of this page is the last traded price from exchange data; during market hours it refreshes on its own. The Chart & Technicals section has the full price history.

Where are the financial results?

The Financials page has quarterly and annual results, ratios, cash flow and the balance sheet, on a standalone or consolidated basis.

Who owns the company?

The Ownership section shows the latest shareholding pattern from exchange filings, with promoter, FII, DII and public holdings by quarter.

Does Tradinity give buy or sell advice?

No. The scores and checklist on this page are rule-based summaries of published figures, not recommendations. Tradinity is not a registered investment adviser.